
TastepepAI: An artificial intelligence platform for taste peptide de novo design.
AI Revolutionizes Taste Peptide Design: 73 New Flavors Discovered! π½οΈπ€
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
AI Revolutionizes Taste Peptide Design: 73 New Flavors Discovered! π½οΈπ€
AI tool ProRNA3D-single enhances visualization of disease mechanisms, aiding drug discovery for viruses and Alzheimerβs. π§¬π‘
AI-Enhanced CRISPR technology could speed up gene therapy development, making it accessible to more researchers. π§¬π€
Machine learning enhances bioactive compound discovery, identifying neuraminidase inhibitors with IC50 of 16.8 ΞΌM. πΏπ¬
AI enhances T-cell immunotherapy and vaccine development, improving predictions of T cell responses. π€π
Cybersecurity in Drug Discovery: Protecting Data & Compliance ππ
AI improves Crohn’s disease evaluation via colonoscopy, matching gastroenterologists’ performance in identifying mucosal ulceration. π€π
MIT researchers have developed new antibiotics using AI to target drug-resistant bacteria like MRSA and gonorrhea. π¦ π
AI revolutionizes drug discovery, reducing costs by 30% and development time by 50%. Ethical challenges persist. π€π
AI aids in designing nanoparticles for RNA vaccine delivery, enhancing efficiency and potential treatments for various diseases. π§¬π